in contrast , anti-inflammatory doses of sodium salicylate and an experimental drug bw755c ( 3-amino-1m- ( trifluoromethyl ) -phenyl-2-pyrazoline ) fail to inhibit gastric mucosal prostacyclin formation ( but do reduce prostaglandin levels in the inflammatory exudate ) and cause only minimal gastric damage , supporting the relationship between production of gastric erosions and the inhibition of mucosal prostacyclin production .
C0017136
gastric
C0038351
gastric